Investigating siRNA-mediated inhibition of ischemia-reperfusion injury during the liver transplantation process
研究肝移植过程中 siRNA 介导的缺血再灌注损伤抑制作用
基本信息
- 批准号:10740842
- 负责人:
- 金额:$ 3.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcetylgalactosamineAffectApoptosisBiochemical MarkersBlood VesselsCD95 AntigensCell DeathCessation of lifeChemicalsChemistryClinicalClosure by clampCryopreservationEuthanasiaFDA approvedGene ExpressionGenesGoalsHepatic TissueHepatocyteHistologyHourHumanIn VitroIndividualInflammationInflammatoryInflammatory InfiltrateInnate Immune ResponseIschemiaLiverLiver DysfunctionLiver FailureLiver diseasesMeasuresMediatingMediatorMessenger RNAModelingNecrosisNeutrophil InfiltrationOrganOutcomeOxidative StressPathologyPathway interactionsPatientsPerfusionPharmaceutical PreparationsProcessProteinsRattusReperfusion InjuryReperfusion TherapySmall Interfering RNASmall RNATechnologyTestingTractionTransaminasesTransplantationWaiting Listscell injurycytokinedesignend stage liver diseaseexperimental studyimplantationimprovedin vivoin vivo imaginginnate immune pathwaysknock-downliver functionliver inflammationliver injuryliver ischemialiver preservationliver transplantationmortalityoxidative damagepreservationreceptorresponse to injurystandard caresubcutaneoustherapy developmenttranscriptometranscriptome sequencinguptake
项目摘要
PROJECT SUMMARY
Liver transplantation is the only cure for liver failure, but many patients die waiting for a transplant due to a vast
shortage of donor livers. Insufficient donor supply is further diminished by ischemia-reperfusion injury (IRI) during
procurement and preservation of liver grafts. IRI-damaged grafts must be discarded because they are
dysfunctional following implantation into recipients, causing patient death. Mitigating IRI is critically needed to
increase the number of viable donor livers and improve patient survival. The IRI mechanism involves several
pathways. After ischemic insult facilitates cellular injury, reperfusion triggers oxidative stress and innate immune
pathways that converge to activate apoptosis, the major cell death mechanism in liver IRI. Hepatocyte apoptosis
in IRI is mediated by Fas receptor (Fas), and leads to necrosis and inflammation, which cause liver dysfunction.
In rats, Fas reduction prior to ischemia reduces liver damage. It may be possible to mitigate IRI-induced liver
dysfunction by silencing hepatocyte-specific Fas during the transplantation process.
The goal of this proposal is to use small interfering RNA (siRNA) to inhibit IRI and improve quality of liver grafts
for transplantation. Chemically-modified siRNAs enable potent, sequence-specific silencing of any target gene
in vivo. Modified siRNAs are delivered to hepatocytes when conjugated with N-acetylgalactosamine (GalNAc).
GalNAc-siRNA technology is the basis of numerous FDA-approved liver disease drugs. With guidance from Drs.
Anastasia Khvorova (siRNA), Paulo Martins (liver transplant), Athma Pai (RNA seq), Gyongyi Szabo (liver IRI),
Jacob Bledsoe (liver pathology), and Matthew Gounis (in vivo imaging), this project will develop in vivo and ex
vivo approaches using previously-validated GalNAc-siRNA targeting Fas to inhibit IRI and protect liver function.
Aim 1 will determine how silencing Fas prior to ischemia perturbs IRI pathways (Aim 1.1), and explore if silencing
Fas in combination with other mediators confers greater protection against liver damage (Aim 1.2). GalNAc-
siRNAs targeting Fas, alone, or in combination with validated oxidative stress (Hmgb1) and inflammation (Tnfr1)
mediators, will be injected into rats, and IRI will be induced using a liver clamp model. Post-reperfusion, target
gene expression, liver damage, and IRI transcriptome changes will be assessed. Aim 2 will determine how
silencing Fas in liver grafts (ex vivo) affects transplant outcomes in rats. Delivering siRNA during ex vivo
preservation, by either static cold storage (SCS) or machine perfusion (MP), leads to uptake into liver grafts. Rat
livers will be procured and GalNAc-siRNA targeting Fas will be delivered during SCS or MP. GalNAc-siRNA
uptake, Fas expression, and IRI transcriptome changes will be assessed over 24 hours. This experiment will
then be repeated, preserving grafts for maximal GalNAc-siRNA uptake/efficacy, transplanting grafts into rats,
and measuring liver damage/function and recipient survival. Study findings will characterize how Fas silencing
pre- and post-ischemia affects liver IRI pathways, identify in vivo and ex vivo approaches for maximal IRI
inhibition, and help develop therapies that increase the donor pool and improve patient survival.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julianna E Buchwald其他文献
Julianna E Buchwald的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julianna E Buchwald', 18)}}的其他基金
Investigating siRNA-mediated inhibition of ischemia-reperfusion injury during the liver transplantation process
研究肝移植过程中 siRNA 介导的缺血再灌注损伤抑制作用
- 批准号:
10537869 - 财政年份:2022
- 资助金额:
$ 3.25万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 3.25万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 3.25万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 3.25万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 3.25万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 3.25万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 3.25万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 3.25万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 3.25万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 3.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 3.25万 - 项目类别:
Studentship